These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 10490030

  • 1. Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor.
    Wiesmann C, Ultsch MH, Bass SH, de Vos AM.
    Nature; 1999 Sep 09; 401(6749):184-8. PubMed ID: 10490030
    [Abstract] [Full Text] [Related]

  • 2. Crystal structures of the neurotrophin-binding domain of TrkA, TrkB and TrkC.
    Ultsch MH, Wiesmann C, Simmons LC, Henrich J, Yang M, Reilly D, Bass SH, de Vos AM.
    J Mol Biol; 1999 Jul 02; 290(1):149-59. PubMed ID: 10388563
    [Abstract] [Full Text] [Related]

  • 3. Neurotrophin-3 acquires NGF-like activity after exchange to five NGF amino acid residues: molecular analysis of the sites in NGF mediating the specific interaction with the NGF high affinity receptor.
    Kullander K, Ebendal T.
    J Neurosci Res; 1994 Oct 01; 39(2):195-210. PubMed ID: 7837289
    [Abstract] [Full Text] [Related]

  • 4. Immunoglobulin-like domains define the nerve growth factor binding site of the TrkA receptor.
    Holden PH, Asopa V, Robertson AG, Clarke AR, Tyler S, Bennett GS, Brain SD, Wilcock GK, Allen SJ, Smith SK, Dawbarn D.
    Nat Biotechnol; 1997 Jul 01; 15(7):668-72. PubMed ID: 9219271
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Nerve growth factor induces a multimeric TrkA receptor complex in neuronal cells that includes Crk, SHC and PLC-gamma 1 but excludes P130CAS.
    Torres M, Bogenmann E.
    Oncogene; 1996 Jan 04; 12(1):77-86. PubMed ID: 8552402
    [Abstract] [Full Text] [Related]

  • 7. Specificity determinants in neurotrophin-3 and design of nerve growth factor-based trkC agonists by changing central beta-strand bundle residues to their neurotrophin-3 analogs.
    Urfer R, Tsoulfas P, O'Connell L, Presta LG.
    Biochemistry; 1997 Apr 22; 36(16):4775-81. PubMed ID: 9125498
    [Abstract] [Full Text] [Related]

  • 8. Structure of nerve growth factor complexed with the shared neurotrophin receptor p75.
    He XL, Garcia KC.
    Science; 2004 May 07; 304(5672):870-5. PubMed ID: 15131306
    [Abstract] [Full Text] [Related]

  • 9. Immunological determinants of nerve growth factor involved in p140trk (Trk) receptor binding.
    Nanduri J, Vroegop SM, Buxser SE, Neet KE.
    J Neurosci Res; 1994 Mar 01; 37(4):433-44. PubMed ID: 7517456
    [Abstract] [Full Text] [Related]

  • 10. Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: a structural insight.
    Covaceuszach S, Cattaneo A, Lamba D.
    Proteins; 2005 Feb 15; 58(3):717-27. PubMed ID: 15625712
    [Abstract] [Full Text] [Related]

  • 11. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75.
    Casaccia-Bonnefil P, Carter BD, Dobrowsky RT, Chao MV.
    Nature; 1996 Oct 24; 383(6602):716-9. PubMed ID: 8878481
    [Abstract] [Full Text] [Related]

  • 12. Nerve growth factor stimulates clonal growth of human lung cancer cell lines and a human glioblastoma cell line expressing high-affinity nerve growth factor binding sites involving tyrosine kinase signaling.
    Oelmann E, Sreter L, Schuller I, Serve H, Koenigsmann M, Wiedenmann B, Oberberg D, Reufi B, Thiel E, Berdel WE.
    Cancer Res; 1995 May 15; 55(10):2212-9. PubMed ID: 7538048
    [Abstract] [Full Text] [Related]

  • 13. Retrograde axonal transport and lesion-induced upregulation of the TrkA high-affinity NGF receptor.
    Loy R, Lachyankar MB, Condon PJ, Poluha DK, Ross AH.
    Exp Neurol; 1994 Dec 15; 130(2):377-86. PubMed ID: 7532592
    [Abstract] [Full Text] [Related]

  • 14. Induction of cell death by endogenous nerve growth factor through its p75 receptor.
    Frade JM, Rodríguez-Tébar A, Barde YA.
    Nature; 1996 Sep 12; 383(6596):166-8. PubMed ID: 8774880
    [Abstract] [Full Text] [Related]

  • 15. Identification and structure of the nerve growth factor binding site on TrkA.
    Robertson AG, Banfield MJ, Allen SJ, Dando JA, Mason GG, Tyler SJ, Bennett GS, Brain SD, Clarke AR, Naylor RL, Wilcock GK, Brady RL, Dawbarn D.
    Biochem Biophys Res Commun; 2001 Mar 23; 282(1):131-41. PubMed ID: 11263982
    [Abstract] [Full Text] [Related]

  • 16. Characterization of the recombinant extracellular domain of the neurotrophin receptor TrkA and its interaction with nerve growth factor (NGF).
    Woo SB, Whalen C, Neet KE.
    Protein Sci; 1998 Apr 23; 7(4):1006-16. PubMed ID: 9568907
    [Abstract] [Full Text] [Related]

  • 17. Structural and mechanistic insights into nerve growth factor interactions with the TrkA and p75 receptors.
    Wehrman T, He X, Raab B, Dukipatti A, Blau H, Garcia KC.
    Neuron; 2007 Jan 04; 53(1):25-38. PubMed ID: 17196528
    [Abstract] [Full Text] [Related]

  • 18. Regulation of NGF responsiveness in human neuroblastoma.
    Bogenmann E, Peterson S, Maekawa K, Matsushima H.
    Oncogene; 1998 Nov 05; 17(18):2367-76. PubMed ID: 9811468
    [Abstract] [Full Text] [Related]

  • 19. Structure and ligand recognition of the phosphotyrosine binding domain of Shc.
    Zhou MM, Ravichandran KS, Olejniczak EF, Petros AM, Meadows RP, Sattler M, Harlan JE, Wade WS, Burakoff SJ, Fesik SW.
    Nature; 1995 Dec 07; 378(6557):584-92. PubMed ID: 8524391
    [Abstract] [Full Text] [Related]

  • 20. Structure-function analyses of the kit receptor for the steel factor.
    Blechman JM, Lev S, Givol D, Yarden Y.
    Stem Cells; 1993 Jul 07; 11 Suppl 2():12-21. PubMed ID: 7691317
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.